Cargando…
Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia
Acute myeloid leukaemia (AML) is a heterogeneous disease with one of the worst survival rates of all cancers. The bone marrow microenvironment is increasingly being recognised as an important mediator of AML chemoresistance and relapse, supporting leukaemia stem cell survival through interactions am...
Autores principales: | Skelding, Kathryn A., Barry, Daniel L., Theron, Danielle Z., Lincz, Lisa F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820412/ https://www.ncbi.nlm.nih.gov/pubmed/36614005 http://dx.doi.org/10.3390/ijms24010563 |
Ejemplares similares
-
Targeting the two-pore channel 2 in cancer progression and metastasis
por: Skelding, Kathryn A., et al.
Publicado: (2022) -
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020) -
Targeting N-cadherin (CDH2) and the malignant bone marrow microenvironment in acute leukaemia
por: Parker, Jessica, et al.
Publicado: (2023) -
PARP Inhibitors and Haematological Malignancies—Friend or Foe?
por: Skelding, Kathryn A., et al.
Publicado: (2021) -
T cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
por: Hawkins, Edwin D, et al.
Publicado: (2016)